FDA Okays Plan to Allow Restricted Use of Tegaserod (Zelnorm)
July 27th 2007ROCKVILLE, Md. -- Tegaserod (Zelnorm), the irritable bowel syndrome and constipation drug pulled from the market last spring, will make a limited return under an FDA plan that permits its use in certain symptomatic women younger than 55.